These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37555752)

  • 1. Economic and health impact modelling of a whole genome sequencing-led intervention strategy for bacterial healthcare-associated infections for England and for the USA.
    Fox JM; Saunders NJ; Jerwood SH
    Microb Genom; 2023 Aug; 9(8):. PubMed ID: 37555752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the economic effects of genomic sequencing of pathogens to prioritise hospital patients competing for isolation beds.
    Elliott TM; Hare N; Hajkowicz K; Hurst T; Doidge M; Harris PN; Gordon LG
    Aust Health Rev; 2021 Feb; 45(1):59-65. PubMed ID: 33049199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia.
    Gordon LG; Elliott TM; Forde B; Mitchell B; Russo PL; Paterson DL; Harris PNA
    BMJ Open; 2021 Feb; 11(2):e041968. PubMed ID: 33526501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial and economic costs of healthcare-associated infections in Africa.
    Hutton G; Chase C; Kennedy-Walker R; Hamilton H
    J Hosp Infect; 2024 Aug; 150():1-8. PubMed ID: 38723903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings.
    Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
    Acta Clin Belg; 2013; 68(3):199-205. PubMed ID: 24156220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-Genome Sequencing Surveillance and Machine Learning of the Electronic Health Record for Enhanced Healthcare Outbreak Detection.
    Sundermann AJ; Chen J; Kumar P; Ayres AM; Cho ST; Ezeonwuka C; Griffith MP; Miller JK; Mustapha MM; Pasculle AW; Saul MI; Shutt KA; Srinivasa V; Waggle K; Snyder DJ; Cooper VS; Van Tyne D; Snyder GM; Marsh JW; Dubrawski A; Roberts MS; Harrison LH
    Clin Infect Dis; 2022 Aug; 75(3):476-482. PubMed ID: 34791136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of healthcare-associated infections: an American perspective.
    Stone PW
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):417-22. PubMed ID: 19817525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method for Economic Evaluation of Bacterial Whole Genome Sequencing Surveillance Compared to Standard of Care in Detecting Hospital Outbreaks.
    Kumar P; Sundermann AJ; Martin EM; Snyder GM; Marsh JW; Harrison LH; Roberts MS
    Clin Infect Dis; 2021 Jul; 73(1):e9-e18. PubMed ID: 32367125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the annual NHS costs and outcomes attributable to healthcare-associated infections in England.
    Guest JF; Keating T; Gould D; Wigglesworth N
    BMJ Open; 2020 Jan; 10(1):e033367. PubMed ID: 31974088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling.
    Mugwagwa T; Abubakar I; White PJ
    Thorax; 2021 Mar; 76(3):281-291. PubMed ID: 33542086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial impact of healthcare-associated infections on intensive care units estimated for fifty Brazilian university hospitals affiliated to the unified health system.
    Osme SF; Souza JM; Osme IT; Almeida APS; Arantes A; Mendes-Rodrigues C; Gontijo Filho PP; Ribas RM
    J Hosp Infect; 2021 Nov; 117():96-102. PubMed ID: 34461175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of whole genome sequencing for pathogen identification and surveillance - results of case studies in Europe and the Americas 2016 to 2019.
    Alleweldt F; Kara Ş; Best K; Aarestrup FM; Beer M; Bestebroer TM; Campos J; Casadei G; Chinen I; Van Domselaar G; Dominguez C; Everett HE; Fouchier RA; Grant K; Green J; Höper D; Johnston J; Koopmans MP; Oude Munnink BB; Myers R; Nadon C; Patel A; Pohlmann A; Pongolini S; Reimer A; Thiessen S; Wylezich C
    Euro Surveill; 2021 Mar; 26(9):. PubMed ID: 33663647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the cost implications of integrating SARS-CoV-2 genome sequencing for infection prevention and control investigation of nosocomial transmission within hospitals.
    Panca M; Blackstone J; Stirrup O; Cutino-Moguel MT; Thomson E; Peters C; Snell LB; Nebbia G; Holmes A; Chawla A; Machin N; Taha Y; Mahungu T; Saluja T; de Silva TI; Saeed K; Pope C; Shin GY; Williams R; Darby A; Smith DL; Loose M; Robson SC; Laing K; Partridge DG; Price JR; Breuer J
    J Hosp Infect; 2023 Sep; 139():23-32. PubMed ID: 37308063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underresourced hospital infection control and prevention programs: penny wise, pound foolish?
    Anderson DJ; Kirkland KB; Kaye KS; Thacker PA; Kanafani ZA; Auten G; Sexton DJ
    Infect Control Hosp Epidemiol; 2007 Jul; 28(7):767-73. PubMed ID: 17564977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of economic evaluations of whole-genome sequencing for the surveillance of bacterial pathogens.
    Price V; Ngwira LG; Lewis JM; Baker KS; Peacock SJ; Jauneikaite E; Feasey N
    Microb Genom; 2023 Feb; 9(2):. PubMed ID: 36790430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Genome Sequencing of Bacterial Pathogens: the Future of Nosocomial Outbreak Analysis.
    Quainoo S; Coolen JPM; van Hijum SAFT; Huynen MA; Melchers WJG; van Schaik W; Wertheim HFL
    Clin Microbiol Rev; 2017 Oct; 30(4):1015-1063. PubMed ID: 28855266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study.
    Su LH; Chen IL; Tang YF; Lee JS; Liu JW
    PLoS One; 2020; 15(5):e0233265. PubMed ID: 32421700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding an Economic Evaluation of the Veterans Affairs (VA) Methicillin-resistant Staphylococcus aureus (MRSA) Prevention Initiative to Include Prevention of Infections From Other Pathogens.
    Nelson RE; Goto M; Samore MH; Jones M; Stevens VW; Evans ME; Schweizer ML; Perencevich EN; Rubin MA
    Clin Infect Dis; 2021 Jan; 72(Suppl 1):S50-S58. PubMed ID: 33512526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal trends in all healthcare-associated infections through comprehensive hospital-wide surveillance and infection control measures over the past 12 years: substantial burden of healthcare-associated infections outside of intensive care units and "other" types of infection.
    Kanamori H; Weber DJ; DiBiase LM; Sickbert-Bennett EE; Brooks R; Teal L; Williams D; Walters EM; Rutala WA
    Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1139-47. PubMed ID: 26108686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.